- Sputnik International, 1920
World
Get the latest news from around the world, live coverage, off-beat stories, features and analysis.

Palestinians Say Israel Preventing Russian Coronavirus Vaccine Deliveries to Gaza - Reports

© AP Photo / Zoltan BaloghA vial containing Russian vaccine Sputnik V is shown by a nurse at the South Pest Central Hospital in Budapest, Hungary, Friday, Feb. 12, 2021, as the vaccination with Sputnik V against the new coronavirus begins in the country.
A vial containing Russian vaccine Sputnik V is shown by a nurse at the South Pest Central Hospital in Budapest, Hungary, Friday, Feb. 12, 2021, as the vaccination with Sputnik V against the new coronavirus begins in the country. - Sputnik International, 1920, 16.02.2021
Subscribe
MOSCOW (Sputnik) - Palestinian Health Minister Mai al-Kaila has accused Israel of preventing the delivery of Russia’s Sputnik V coronavirus vaccine doses to the Gaza Strip, the Palestine news agency (WAFA) reports.

Mai al-Kaila said that on Monday a Sputnik V shipment intended for health workers was sent to Gaza but Israel prevented it from reaching its destination.

The health minister stressed that such actions run contrary to all laws and international agreements.

Palestinian Authority was the first country in the Middle East to register Russia’s Sputnik V vaccine. The coronavirus vaccination campaign in Palestine kicked off at the start of February, with medical personnel being the first in line.

A medical worker prepares to administer a second vaccination injection against the coronavirus disease as Israel continues its national vaccination drive, during a third national COVID-19 lockdown, at Tel Aviv Sourasky Medical Center (Ichilov Hospital) in Tel Aviv, Israel January 10, 2021 - Sputnik International, 1920, 24.01.2021
With Israel Still Leading in Pace of Vaccination, Palestinians Have Yet to Receive Their First Jabs
A recent peer-reviewed study published in The Lancet journal stated that Sputnik V, which was developed by Russia's Gamaleya Research Center of Epidemiology and Microbiology, showed 91.6 percent efficacy, based on Phase 3 clinical trial interim data. The vaccine, which is built on a human adenoviral vector platform, was registered by the Russian government on August 11.

Over 20 countries have already authorized the emergency use of Sputnik V.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала